Park S, Ahn Y, Lee H, Hong E, Ryu J. Standardized Prunella vulgaris var. lilacina Extract Enhances Cognitive Performance in Normal Naive Mice. Phytother Res. 2015;29:1814-21 pubmed publisher

Gao Q, Jeon S, Jung H, Lee H, Park S, Lee Y, et al. Nodakenin Enhances Cognitive Function and Adult Hippocampal Neurogenesis in Mice. Neurochem Res. 2015;40:1438-47 pubmed publisher

Bang S, Ambavade S, Jagdale P, Adkar P, Waghmare A, Ambavade P. Lacosamide reduces HDAC levels in the brain and improves memory: Potential for treatment of Alzheimer's disease. Pharmacol Biochem Behav. 2015;134:65-9 pubmed publisher

Sendrowski K, Sobaniec W, Stasiak Barmuta A, Sobaniec P, Popko J. Study of the protective effects of nootropic agents against neuronal damage induced by amyloid-beta (fragment 25-35) in cultured hippocampal neurons. Pharmacol Rep. 2015;67:326-31 pubmed publisher

Li B, Calvet A, Casamayou Boucau Y, Morris C, Ryder A. Low-content quantification in powders using Raman spectroscopy: a facile chemometric approach to sub 0.1% limits of detection. Anal Chem. 2015;87:3419-28 pubmed publisher

Palit P, Mukherjee D, Mandal S. Reconstituted mother tinctures of Gelsemium sempervirens L. improve memory and cognitive impairment in mice scopolamine-induced dementia model. J Ethnopharmacol. 2015;159:274-84 pubmed publisher

Tóth A, Tóth A, Walter F, Kiss L, Veszelka S, Ózsvári B, et al. Compounds blocking methylglyoxal-induced protein modification and brain endothelial injury. Arch Med Res. 2014;45:753-64 pubmed publisher

Mrozikiewicz P, Bogacz A, Bartkowiak Wieczorek J, Kujawski R, Mikolajczak P, Ozarowski M, et al. Screening for impact of popular herbs improving mental abilities on the transcriptional level of brain transporters. Acta Pharm. 2014;64:223-32 pubmed publisher

Zaccara G, Almas M, Pitman V, Knapp L, Posner H. Efficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: a randomized, double-blind, noninferiority trial. Epilepsia. 2014;55:1048-57 pubmed publisher

Mehta A, Bhati Y, Tripathi C, Sharma K. Analgesic effect of piracetam on peripheral neuropathic pain induced by chronic constriction injury of sciatic nerve in rats. Neurochem Res. 2014;39:1433-9 pubmed publisher

Burakgazi E, Bashir S, Doss V, Pellock J. The safety and tolerability of different intravenous administrations of levetiracetam, bolus versus infusion, in intensive care unit patients. Clin EEG Neurosci. 2014;45:89-91 pubmed publisher

Iyoda K, Ogawa K, Okazaki T. [Efficacy and psychiatric adverse events as short-term adjunctive levetiracetam for epileptic children with refractory convulsive seizures]. No To Hattatsu. 2013;45:463-4 pubmed

Wakita M, Kotani N, Kogure K, Akaike N. Inhibition of excitatory synaptic transmission in hippocampal neurons by levetiracetam involves Zn²⁺-dependent GABA type A receptor-mediated presynaptic modulation. J Pharmacol Exp Ther. 2014;348:246-59 pubmed publisher

Kikuchi T, Kato M, Takahashi N, Nakamura K, Hayasaka K. [Epileptic encephalopathy associated with forced normalization after administration of levetiracetam]. No To Hattatsu. 2013;45:375-8 pubmed

Kwiecińska P, WROBEL A, Taubøll E, Gregoraszczuk E. Valproic acid, but not levetiracetam, selectively decreases HDAC7 and HDAC2 expression in human ovarian cancer cells. Toxicol Lett. 2014;224:225-32 pubmed publisher

Nakamura H, Osawa M, Yokoyama T, Yoshida K, Suzuki A. [Efficacy and safety of levetiracetam as adjunctive therapy in Japanese children with uncontrolled partial-onset seizures: multicenter and open-label study (N01223), short term evaluation]. Brain Nerve. 2013;65:1083-92 pubmed

Bleck T, Cock H, Chamberlain J, Cloyd J, Connor J, Elm J, et al. The established status epilepticus trial 2013. Epilepsia. 2013;54 Suppl 6:89-92 pubmed publisher

Kang B, Moon H, Kim Y, Lee S, Jung K, Chu K, et al. The long-term efficacy and safety of levetiracetam in a tertiary epilepsy centre. Epileptic Disord. 2013;15:302-10 pubmed publisher

Kim D, Lee S, Shon Y, Kim J. Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy. Epilepsia. 2013;54:e146-9 pubmed publisher

Pearl P, McCarter R, McGavin C, Yu Y, Sandoval F, Trzcinski S, et al. Results of phase II levetiracetam trial following acute head injury in children at risk for posttraumatic epilepsy. Epilepsia. 2013;54:e135-7 pubmed publisher

Barrera Bailón B, Oliveira J, Lopez D, Muñoz L, Garcia Cairasco N, Sancho C. Pharmacological and neuroethological studies of three antiepileptic drugs in the Genetic Audiogenic Seizure Hamster (GASH:Sal). Epilepsy Behav. 2013;28:413-25 pubmed publisher

Connor J, Elm J, Broglio K. Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus. J Clin Epidemiol. 2013;66:S130-7 pubmed publisher

Tanaka S, Tanaka T. Levetiracetam add-on therapy in Japanese patients with refractory partial epilepsy. Epileptic Disord. 2013;15:132-41 pubmed publisher

Tiurenkov I, Samotrueva M, Priluchnyĭ S. [Psychomodulating activity of phenotropil in experimental hyperthyroidism]. Eksp Klin Farmakol. 2013;76:18-21 pubmed

Muley M, Thakare V, Patil R, Bafna P, Naik S. Amelioration of cognitive, motor and endogenous defense functions with silymarin, piracetam and protocatechuic acid in the cerebral global ischemic rat model. Life Sci. 2013;93:51-7 pubmed publisher

Palermo A, Giglia G, Cosentino G, Raieli V, Brighina F, Fierro B. Two cases of cluster headache effectively treated with levetiracetam. Funct Neurol. 2013;28:63-4 pubmed

Garbossa D, Panciani P, Angeleri R, Battaglia L, Tartara F, Ajello M, et al. A retrospective two-center study of antiepileptic prophylaxis in patients with surgically treated high-grade gliomas. Neurol India. 2013;61:131-7 pubmed publisher

Dedea L. Phenytoin or levetiracetam for seizure prophylaxis in TBI. JAAPA. 2012;25:11 pubmed

Phabphal K, Geater A, Limapichat K, Sathirapanya P, Setthawatcharawanich S, Leelawattana R. Effect of switching hepatic enzyme-inducer antiepileptic drug to levetiracetam on bone mineral density, 25 hydroxyvitamin D, and parathyroid hormone in young adult patients with epilepsy. Epilepsia. 2013;54:e94-8 pubmed publisher

Mahmoud A, Rizk T, Mansy A, Ali J, Al Tannir M. Ineffectiveness of topiramate and levetiracetam in infantile spasms non-responsive to steroids. Open labeled randomized prospective study. Neurosciences (Riyadh). 2013;18:143-6 pubmed

Yesilova Y, Turan E, Sonmez A, Ozardali I. A case of erythema multiforme developing after levetiracetam therapy. Dermatol Online J. 2013;19:12 pubmed

Nakken K, Sætre E, Markhus R, Lossius M. [Epilepsy in the elderly]. Tidsskr Nor Laegeforen. 2013;133:528-31 pubmed publisher

Inaba K, Menaker J, Branco B, Gooch J, Okoye O, Herrold J, et al. A prospective multicenter comparison of levetiracetam versus phenytoin for early posttraumatic seizure prophylaxis. J Trauma Acute Care Surg. 2013;74:766-71; discussion 771-3 pubmed publisher

Sethi N, Sethi P, Torgovnick J, Arsura E, Cukierwar F. Asymptomatic elevation of liver enzymes due to levetiracetam: a case report. Drug Metabol Drug Interact. 2013;28:123-4 pubmed publisher

Kazoka H, Koliškina O, Veinberg G, Vorona M. Separation of piracetam derivatives on polysaccharide-based chiral stationary phases. J Chromatogr A. 2013;1281:160-5 pubmed publisher

Chukanova E, Khodzhamzharov B, Chukanova A. [Current possibilities of the correction of oxidative stress in acute brain ischaemia]. Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112:79-82 pubmed

Bjørnæs H, Bakke K, Larsson P, Heminghyt E, Rytter E, Brager Larsen L, et al. Subclinical epileptiform activity in children with electrical status epilepticus during sleep: effects on cognition and behavior before and after treatment with levetiracetam. Epilepsy Behav. 2013;27:40-8 pubmed publisher

Hubs kyĭ I, Bielenichev I, Kovalenko S, Goriushko H, Bukhtiiarova N, Litvinova N, et al. [Antioxidant and cerebroprotective action of N-,S-chinazolone derivative under rat brain ischemia]. Ukr Biokhim Zh (1999). 2012;84:89-96 pubmed

Costa R, Fernandes M, de Souza Pinto N, Vercesi A. Protective effects of l-carnitine and piracetam against mitochondrial permeability transition and PC3 cell necrosis induced by simvastatin. Eur J Pharmacol. 2013;701:82-6 pubmed publisher

Amieva H, Meillon C, Helmer C, Barberger Gateau P, Dartigues J. Ginkgo biloba extract and long-term cognitive decline: a 20-year follow-up population-based study. PLoS ONE. 2013;8:e52755 pubmed publisher

Duong T, Haddad C, Valeyrie Allanore L, Sbidian E, Chosidow O, Wolkenstein P. Levetiracetam: a possible new inducer of toxic epidermal necrolysis and Stevens-Johnson syndrome in 2 cases. JAMA Dermatol. 2013;149:113-5 pubmed publisher

Mawhinney E, Craig J, Morrow J, Russell A, Smithson W, Parsons L, et al. Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers. Neurology. 2013;80:400-5 pubmed publisher

Lee G, Kim B, Kang J, Lee S. Loss of the initial efficacy of levetiracetam in patients with refractory epilepsy. Seizure. 2013;22:185-8 pubmed publisher

Steinhoff B, Maren Staack A, Wisniewski I. Seizure control with antiepileptic drug therapy in 517 consecutive adult outpatients at the Kork Epilepsy Centre. Epileptic Disord. 2012;14:379-87 pubmed publisher

Almeida D, Jean M, Chystsiakova A, Monahan E, Oliveira S, Monteiro I. Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report. Pancreas. 2013;42:177-8 pubmed publisher

Asadullaev M, Saidvaliev F, Shermukhamedova F, Rizvonov Z, Vakhabova N. [Assessment of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome]. Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112:24-7 pubmed

Zaitone S, Abo Elmatty D, Elshazly S. Piracetam and vinpocetine ameliorate rotenone-induced Parkinsonism in rats. Indian J Pharmacol. 2012;44:774-9 pubmed publisher

Martikainen M, Päivärinta M, Jääskeläinen S, Majamaa K. Successful treatment of POLG-related mitochondrial epilepsy with antiepileptic drugs and low glycaemic index diet. Epileptic Disord. 2012;14:438-41 pubmed publisher

Maschio M, Dinapoli L, Sperati F, Pace A, Fabi A, Vidiri A, et al. Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study. Epileptic Disord. 2012;14:388-97 pubmed publisher

Sönnichsen A. The problem of non-superiority: what do we know after KOMET?. J Neurol Neurosurg Psychiatry. 2013;84:1067 pubmed publisher

Ricci S, Celani M, Cantisani T, Righetti E. Piracetam for acute ischaemic stroke. Cochrane Database Syst Rev. 2012;:CD000419 pubmed publisher

Trinka E, Marson A, Van Paesschen W, Kälviäinen R, Marovac J, Duncan B, et al. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy. J Neurol Neurosurg Psychiatry. 2013;84:1138-47 pubmed publisher

Hofmeyr G, Kulier R. Piracetam for fetal distress in labour. Cochrane Database Syst Rev. 2012;:CD001064 pubmed publisher

Guandalini L, Martini E, Di Cesare Mannelli L, Dei S, Manetti D, Scapecchi S, et al. Influence of ring size on the cognition-enhancing activity of DM235 and MN19, two potent nootropic drugs. Bioorg Med Chem Lett. 2012;22:1936-9 pubmed publisher

Martini E, Di Cesare Mannelli L, Bartolucci G, Bertucci C, Dei S, Ghelardini C, et al. Synthesis and biological evaluation of 3,7-diazabicyclo[4.3.0]nonan-8-ones as potential nootropic and analgesic drugs. J Med Chem. 2011;54:2512-6 pubmed publisher

Malykh A, Sadaie M. Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders. Drugs. 2010;70:287-312 pubmed publisher

Ahmed A, Oswald R. Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors. J Med Chem. 2010;53:2197-203 pubmed publisher

Martini E, Salvicchi A, Ghelardini C, Manetti D, Dei S, Guandalini L, et al. Design, synthesis and nootropic activity of new analogues of sunifiram and sapunifiram, two potent cognition-enhancers. Bioorg Med Chem. 2009;17:7606-14 pubmed publisher

Martini E, Norcini M, Ghelardini C, Manetti D, Dei S, Guandalini L, et al. Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators. Bioorg Med Chem. 2008;16:10034-42 pubmed publisher

Wheble P, Sena E, Macleod M. A systematic review and meta-analysis of the efficacy of piracetam and piracetam-like compounds in experimental stroke. Cerebrovasc Dis. 2008;25:5-11 pubmed

Marwaha A, Goel R, Mahajan M. PASS-predicted design, synthesis and biological evaluation of cyclic nitrones as nootropics. Bioorg Med Chem Lett. 2007;17:5251-5 pubmed

Al Hajeri A, Fedorowicz Z, Omran A, Tadmouri G. Piracetam for reducing the incidence of painful sickle cell disease crises. Cochrane Database Syst Rev. 2007;:CD006111 pubmed

Diamandis P, Wildenhain J, Clarke I, Sacher A, Graham J, Bellows D, et al. Chemical genetics reveals a complex functional ground state of neural stem cells. Nat Chem Biol. 2007;3:268-73 pubmed

Ricci S, Celani M, Cantisani A, Righetti E. Piracetam for acute ischaemic stroke. Cochrane Database Syst Rev. 2006;:CD000419 pubmed

Winnicka K, Tomasiak M, Bielawska A. Piracetam--an old drug with novel properties?. Acta Pol Pharm. 2005;62:405-9 pubmed

Winblad B. Piracetam: a review of pharmacological properties and clinical uses. CNS Drug Rev. 2005;11:169-82 pubmed

Ricci S, Celani M, Cantisani A, Righetti E. Piracetam for acute ischaemic stroke. Cochrane Database Syst Rev. 2002;:CD000419 pubmed

Kondakor I. [Effects of piracetam on the cognitive functions verified by electrophysiologic methods]. Orv Hetil. 2002;143:1129-33 pubmed

Hofmeyr G, Kulier R. Piracetam for fetal distress in labour. Cochrane Database Syst Rev. 2002;:CD001064 pubmed

Gualtieri F, Manetti D, Romanelli M, Ghelardini C. Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs. Curr Pharm Des. 2002;8:125-38 pubmed

Flicker L, Grimley Evans G. Piracetam for dementia or cognitive impairment. Cochrane Database Syst Rev. 2001;:CD001011 pubmed

Tajima K, Nanri M. [A pharmacological profile of piracetam (Myocalm), a drug for myoclonus]. Nihon Yakurigaku Zasshi. 2000;116:209-14 pubmed

Genton P, Van Vleymen B. Piracetam and levetiracetam: close structural similarities but different pharmacological and clinical profiles. Epileptic Disord. 2000;2:99-105 pubmed

Flicker L, Grimley Evans J. Piracetam for dementia or cognitive impairment. Cochrane Database Syst Rev. 2000;:CD001011 pubmed

Ricci S, Celani M, Cantisani A, Righetti E. Piracetam for acute ischaemic stroke. Cochrane Database Syst Rev. 2000;:CD000419 pubmed

Hofmeyr G, Kulier R. Piracetam for fetal distress in labour. Cochrane Database Syst Rev. 2000;:CD001064 pubmed

Noorbala A, Akhondzadeh S, Davari Ashtiani R, Amini Nooshabadi H. Piracetam in the treatment of schizophrenia: implications for the glutamate hypothesis of schizophrenia. J Clin Pharm Ther. 1999;24:369-74 pubmed

Ruthrich H, Grecksch G, Krug M. Effects of piracetam on pentylenetetrazol-kindling development, hippocampal potentiation phenomena and kindling-induced learning deficit. Naunyn Schmiedebergs Arch Pharmacol. 1999;360:413-20 pubmed

Gallinat J, Moller H, Hegerl U. [Piracetam in anesthesia for prevention of postoperative delirium]. Anasthesiol Intensivmed Notfallmed Schmerzther. 1999;34:520-7 pubmed

Oosterveld W. The effectiveness of piracetam in vertigo. Pharmacopsychiatry. 1999;32 Suppl 1:54-60 pubmed

Gouliaev A, Senning A. Piracetam and other structurally related nootropics. Brain Res Brain Res Rev. 1994;19:180-222 pubmed